Medtronic director awarded 1,444 share units

Jellison William R reported acquisition or exercise transactions in this Form 4 filing.

Accepted by SEC EDGAR 04/29/2026 - 04:15 PM EDT

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Jellison William R reported acquisition or exercise transactions in this Form 4 filing.

Medtronic plc director William R. Jellison received an equity award of 1,444 ordinary shares at a price of $0.00 per share. This reflects a grant or award, not an open-market purchase. Following the award, he directly owns 6,444 ordinary shares.

According to the footnote, the grant represents restricted stock units that vest on the one-year anniversary of the award date, tying the compensation to continued service over that period.

Insider Trade Summary

Grant/Award: 1,444 shares

Grant/Award 1 txn

Insider Jellison William R

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Ordinary Shares	1,444	$0.00	$0.00

Holdings After Transaction: Ordinary Shares — 6,444 shares (Direct)

Footnotes (1)

F1. Represents an award of restricted stock units that vest on the one-year anniversary of the award date.

Key Figures

Shares granted: 1,444 shares Grant price per share: $0.00 per share Shares owned after grant: 6,444 shares

3 metrics

Shares granted 1,444 shares Equity award coded as grant/award acquisition

Grant price per share $0.00 per share Compensation-related award, not open-market purchase

Shares owned after grant 6,444 shares Total direct Medtronic ordinary shares following transaction

Key Terms

restricted stock units, grant, award, or other acquisition, ordinary shares, Form 4

4 terms

restricted stock units financial

"Represents an award of restricted stock units that vest on the one-year anniversary"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

ordinary shares financial

"security_title: Ordinary Shares"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Medtronic (MDT) director William R. Jellison report in this Form 4?

William R. Jellison reported receiving an award of 1,444 Medtronic ordinary shares at $0.00 per share. The filing classifies this as a grant or award acquisition, meaning it is compensation-related rather than an open-market stock purchase or sale.

Are the Medtronic (MDT) shares Jellison received restricted stock units?

Yes. A footnote explains the award represents restricted stock units that vest on the one-year anniversary of the award date. These units convert into shares only after vesting, aligning the director’s compensation with continued service over the specified period.

How many Medtronic (MDT) shares does William R. Jellison hold after this grant?

After the reported award, William R. Jellison directly holds 6,444 Medtronic ordinary shares. This figure comes from the Form 4’s post-transaction ownership field and reflects his direct holdings following the 1,444-share compensation grant.

Was there any open-market buying or selling of Medtronic (MDT) shares in this Form 4?

No. The transaction is coded as a grant, award, or other acquisition with a price of $0.00 per share. That indicates a compensation-related equity award rather than an open-market purchase or sale of Medtronic shares by the director.

When do the restricted stock units reported for Medtronic (MDT) vest?

The footnote states that the restricted stock units vest on the one-year anniversary of the award date. This means the director must remain in service for one year from the grant date before the units convert into Medtronic ordinary shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Jellison William R

(Last)

(First)

(Middle)

C/O MEDTRONIC

710 MEDTRONIC PARKWAY

(Street)

MINNEAPOLIS

MINNESOTA

55432

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Medtronic plc [ MDT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Ordinary Shares	04/27/2026		A		1,444⁽¹⁾	A	$0	6,444	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents an award of restricted stock units that vest on the one-year anniversary of the award date.

Remarks:

	/s/ Patricia Walesiewicz, attorney-in-fact	04/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR